Ontology highlight
ABSTRACT:
SUBMITTER: Bruce-Hickman D
PROVIDER: S-EPMC7437943 | biostudies-literature | 2020 Aug
REPOSITORIES: biostudies-literature
Bruce-Hickman Damian D Sajeed Shanaz Matthew SM Pang Yin Huei YH Seow Choon Sheong CS Chen Weihao W Gulati Kansal Monika M
BMJ open gastroenterology 20200801 1
Tocilizumab, a monoclonal antibody against interleukin-6, has been used to treat cytokine release syndrome (CRS) in a subset of patients with severe COVID-19 disease. Acute ulcerative bowel disease has been only rarely documented in patients treated for rheumatological conditions. The gastrointestinal side effects seen when used in the context of COVID-19 are unknown. We present a case of COVID-19 CRS in which acute terminal ileum and perforated caecal ulceration evolved after tocilizumab exposu ...[more]